Company News in the Life Science Industry

»

Reset 

Global Amyloidosis Market Spotlight 2017: Pfizer has Carried Out the Most Phase III Trials in Amyloidosis, Followed by Alnylam

DUBLIN, Feb. 16, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018

Gulf Coast Men's Health Offers GAINSWave in Fort Myers

FORT MYERS, Fla., Feb. 16, 2018 /PRNewswire/ -- Gulf Coast Men's Health is pleased to announce they now offer GAINSWave(TM)! This breakthrough noninvasive medical therapy uses... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018

MNA: Baystate Franklin Medical Center Nurses Schedule One-Day Strike for Wednesday, Feb. 28

GREENFIELD, Mass., Feb. 16, 2018 /PRNewswire-USNewswire/ -- The registered nurses of Baystate Franklin Medical Center, represented by the Massachusetts Nurses Association, will hold a one-day strike on Wednesday, Feb. 28 unless hospital executives agree to a fair contract that protects and improves... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018

Evolus Announces Presentation of Phase III Comparative Data of PrabotulinumtoxinA and OnabotulinumtoxinA

IRVINE, Calif., Feb. 16, 2018 /PRNewswire/ -- Evolus, Inc. (NASDAQ: EOLS) today announced the presentation of data from the Phase III comparative clinical trial of its investigational prabotulinumtoxinA 900 kilodalton (kDa) neuromodulator at the American Academy of Dermatology (AAD) meeting.... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018
Related companies:  Evolus, Inc.

Canfield Scientific Releases the Most Advanced, Fully-Automated, Easy-to-Use IntelliStudio® and Rounds Out Medical Dermatology Line of Imaging Systems

PARSIPPANY, N.J., Feb. 16, 2018 /PRNewswire/ -- At the Annual Meeting of the American Academy of Dermatology (AAD) in San Diego, CA, Canfield Scientific today announced that it is expanding its family of medical dermatology systems with a new fully-automated IntelliStudio® total body photography... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018

Hearing Loss Is Common After Infant Heart Surgery

PHILADELPHIA, Feb. 16, 2018 /PRNewswire-USNewswire/ -- Children who have heart surgery as infants are at risk for hearing loss, coupled with associated risks for language, attention and cognitive problems, by age four. In a single-center group of 348 preschoolers who survived cardiac surgery,... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018

NX Prenatal Expands Pipeline with New Preeclampsia Biomarker Risk Assessment Data

HOUSTON and LOUISVILLE, Ky., Feb. 16, 2018 /PRNewswire/ -- NX Prenatal Inc., a privately held women's healthcare molecular diagnostic company, announced today that new clinical study data will be presented at the Society of Reproductive Investigation's (SRI) 65(th) Annual Scientific Meeting in... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018
Related companies:  University of Colorado School of Medicine - Platte River Prenatal Center

Presence Health Selects R1 RCM for End-to-End Revenue Cycle Management

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

Arcturus Therapeutics Comments on Amended 13D Filing

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

Athenex to Present at 2018 RBC Capital Markets Healthcare Conference

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

NewLink Genetics to Host Its Fourth Quarter and Year End 2017 Financial Results Conference Call on March 1, 2018

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

Diversicare to Announce Fourth Quarter 2017 Financial Results on Thursday, March 1, 2018

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

Editas Medicine Names Jessica Hopfield, Ph.D., to Board of Directors

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

Arch Biopartners Closes Convertible Note Financing

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

Travelan® Revenue Grows Significantly in US and Australia

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

BioStem Technologies Inc. Applies for Uplisting to the OTCQX Market

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

Expert Dermatologists Present Latest Information at 2018 AAD Annual Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

Photocure Announces U.S. FDA Approval of New Indication for Blue Light Cystoscopy with Cysview®

OSLO, Norway, Feb. 16, 2018 /PRNewswire/ -- Photocure ASA (OSE: PHO), announced today that the U.S. Food and Drug Administration (FDA) approved its supplemental new drug application (sNDA) to extend the indication for Blue Light Cystoscopy (BLC(TM)) with Cysview(®) to include... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018
Related companies:  Photocure ASA | Photon Control Inc.

SenzaGen signs its first global licensing agreement with Eurofins BioPharma Product Testing Munich

LUND, Sweden, Feb. 16, 2018 /PRNewswire/ -- SenzaGen (Nasdaq First North: SENZA) announces today that the company has signed a global licensing agreement with the leading contract research organization Eurofins BioPharma Product Testing Munich (Eurofins BPT Munich), to market the... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018
Related companies:  SenzaGen AB

Basketball Legend Al Harrington Premiers "Harrington Wellness" Upscale and Professional Brand of CBD-Based Wellness Products

WOODLAND HILLS, Calif., Feb. 16, 2018 /PRNewswire/ -- Retired NBA great Al Harrington, who discovered the benefits of CBDs (Cannabinoids) at the end of his playing career, has premiered a new line of wellness products based on hemp, the non-psychoactive elements found in the plant. As an upscale... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 40,000 companies